Three-Drug attack aims to shrink 'Cold' tumors for surgery
NCT ID NCT07446465
Summary
This study is testing whether combining three different types of drugs—chemotherapy, an immunotherapy drug, and a targeted therapy—can shrink advanced colorectal tumors enough to make surgery possible. The treatment is for patients whose cancer cannot be removed by surgery when first diagnosed and who have a common type that usually doesn't respond well to immunotherapy alone. The main goal is to see if this combination can successfully convert inoperable cancer into operable cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (LOCALLY ADVANCED OR METASTATIC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Xuhui, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.